PATENT CLAIM ANALYSIS

Application Number: 16003793
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "564000"]

Abstract:
Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction.

Claim (Index 12):
A method of  claim 2 , wherein administering L-4-chlorokynurenine produces a blood plasma level of L-4-chlorokynurenine from about 2 \u03bcg/mL to about 55 \u03bcg/mL within about 0.5 to about 6 hours after its administration.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 94.0
- Lexical Diversity: 1.14286
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15018219', '15978855', '14762015', '15898143', '12452936']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7790463263078841
- 35 USC 102 Novelty (BERT): 0.5440047763126811
- Combined Prediction Score: 0.7555421713083638
- Mean Citation Score: 305.0450140000001
- Max Citation Score: 407.7602
- Similarity Product: 245.0938033907175

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test